SILVER SPRING, MD—Calling it the single greatest breakthrough to date in Alzheimer's research, the U.S. Food and Drug Administration announced Monday the approval of Proneva, a new medication that prevents the degenerative brain disorder by killing individuals before its onset. "Clinical trials have shown that a single dose of Proneva can end the lives of patients who otherwise would have developed a serious and life-threatening illness," said FDA spokeswoman Sandy Walsh, explaining that in a recent study Proneva successfully prevented Alzheimer's in 87 of 87 people who were administered the drug. "For the millions of Americans who already suffer from this disease or have shown early signs of dementia, we recommend commencing treatment as soon as possible." According to Walsh, preliminary research also suggests Proneva may be equally effective at preventing cancer, AIDS, and heart attacks.
More News in Brief
Grown Adult Walks Right Into Karate Studio
CAPE CORAL, FL—Marcus Webster, a full-grown adult with a job, responsibilities, and who stopped being 10 years old over 25 years ago, was observed ...
Woman Apparently Wants To Smell Edible
SAN FRANCISCO—Using such products as pineapple-scented shampoo and raspberry sorbet body wash, 28-year-old Stephanie Holden apparently likes to smell like she wants other people ...
Fans Of Green Screens, Incredibly Fake-Looking Things Express Love For Modern Cinema
NEW YORK—Self-proclaimed fans of artificially sleek movies that at no point appear as though they contain real human beings onscreen in real locations doing ...



146
